<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Physiol</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Physiol. (Lond.)</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1469-7793</journal-id>
<journal-id journal-id-type="publisher-id">TJP</journal-id>
<journal-id journal-id-type="hwp">jphysiol</journal-id>
<journal-title-group>
<journal-title>The Journal of Physiology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0022-3751</issn>
<issn pub-type="epub">1469-7793</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26864773</article-id>
<article-id pub-id-type="pmc">5063927</article-id>
<article-id pub-id-type="doi">10.1113/JP270675</article-id>
<article-id pub-id-type="publisher-id">TJP7142</article-id>
<article-categories>
<subj-group subj-group-type="article-subject-classification">
<subject>Neurological Conditions, Disorders and Treatments</subject>
</subj-group>
<subj-group subj-group-type="article-subject-classification">
<subject>Genetic Conditions Disorders and Treatments</subject>
</subj-group>
<subj-group subj-group-type="article-subject-classification">
<subject>Membrane Physiology</subject>
</subj-group>
<subj-group subj-group-type="overline">
<subject>Symposium Review</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Symposium section reviews: Voltage‐gated calcium channels ‐ from basic mechanisms to disease</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Fragile X mental retardation protein controls ion channel expression and activity</article-title>
<alt-title alt-title-type="left-running-head">L. Ferron</alt-title>
<alt-title alt-title-type="right-running-head">Fragile X mental retardation protein and ion channels</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" id="tjp7142-cr-0001">
<name>
<surname>Ferron</surname>
<given-names>Laurent</given-names>
</name>
<address>
<email>l.ferron@ucl.ac.uk</email>
</address>
<xref ref-type="aff" rid="tjp7142-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="bio" rid="d36e59">*</xref>
</contrib>
</contrib-group>
<aff id="tjp7142-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Neuroscience</named-content>
<named-content content-type="organisation-division">Physiology and Pharmacology</named-content>
<institution>University College London</institution>
<named-content content-type="street">Gower Street, London WC1E 6BT</named-content>
<country country="GB">UK</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Corresponding author</bold> L. Ferron: Department of Neuroscience, Physiology and Pharmacology, University College London, Gower St., London WC1E 6BT, UK. Email: <email>l.ferron@ucl.ac.uk</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>05</day>
<month>5</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<day>15</day>
<month>10</month>
<year>2016</year>
</pub-date>
<volume>594</volume>
<issue>20</issue>
<issue-id pub-id-type="doi">10.1113/tjp.2016.594.issue-20</issue-id>
<fpage>5861</fpage>
<lpage>5867</lpage>
<history>
<date date-type="received">
<day>15</day>
<month>9</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>12</month>
<year>2015</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Journal compilation &#x000a9; 2016 The Physiological Society <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2016 The Authors. The Journal of Physiology © 2016 The Physiological Society</copyright-statement>
</permissions>
<self-uri content-type="pdf" xlink:href="file:TJP-594-5861.pdf" xlink:type="simple"></self-uri>
<abstract>
<title>Abstract</title>
<p>Fragile X‐associated disorders are a family of genetic conditions resulting from the partial or complete loss of fragile X mental retardation protein (FMRP). Among these disorders is fragile X syndrome, the most common cause of inherited intellectual disability and autism. FMRP is an RNA‐binding protein involved in the control of local translation, which has pleiotropic effects, in particular on synaptic function. Analysis of the brain FMRP transcriptome has revealed hundreds of potential mRNA targets encoding postsynaptic and presynaptic proteins, including a number of ion channels. FMRP has been confirmed to bind voltage‐gated potassium channels (K<sub>v</sub>3.1 and K<sub>v</sub>4.2) mRNAs and regulates their expression in somatodendritic compartments of neurons. Recent studies have uncovered a number of additional roles for FMRP besides RNA regulation. FMRP was shown to directly interact with, and modulate, a number of ion channel complexes. The sodium‐activated potassium (Slack) channel was the first ion channel shown to directly interact with FMRP; this interaction alters the single‐channel properties of the Slack channel. FMRP was also shown to interact with the auxiliary β4 subunit of the calcium‐activated potassium (BK) channel; this interaction increases calcium‐dependent activation of the BK channel. More recently, FMRP was shown to directly interact with the voltage‐gated calcium channel, Ca<sub>v</sub>2.2, and reduce its trafficking to the plasma membrane. Studies performed on animal models of fragile X syndrome have revealed links between modifications of ion channel activity and changes in neuronal excitability, suggesting that these modifications could contribute to the phenotypes observed in patients with fragile X‐associated disorders.
<boxed-text content-type="graphic" orientation="portrait" position="anchor"><graphic id="nlm-graphic-3" orientation="portrait" position="anchor" xlink:href="TJP-594-5861-g003.jpg"></graphic></boxed-text>
</p>
</abstract>
<funding-group>
<award-group>
<funding-source>Medical Research Council</funding-source>
<award-id>MR/J013285/1</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="4"></fig-count>
<table-count count="0"></table-count>
<page-count count="7"></page-count>
<word-count count="4903"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>tjp7142</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>15 October 2016</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.9.4 mode:remove_FC converted:13.10.2016</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<fn-group>
<fn id="tjp7142-note-0001">
<p>This review was presented at the symposium “Voltage‐gated calcium channels ‐ from basic mechanisms to disease”, which took place at Physiology 2015, Cardiff, UK between 6–8 July 2015.</p>
</fn>
</fn-group>
</notes>
</front>
</article>
</pmc-articleset>